Austria's Bernhard Kohl, who risks a two-year ban after testing positive to performance-enhancing drugs during this year's Tour de France, said he would reveal how he got the drugs, raising hopes of a breakthrough in the fight against doping.
Austrian Bernhard Kohl, who tested positive for the new generation of erythropoietin, CERA, during the Tour de France, will reveal to Austrian doping officials how he got the drug, his manager said.
"Bernhard is willing to cooperate and he will tell about how he got the substance and how and where he used it," his manager Stefan Matschiner told Cyclingnews (www.cyclingnews.com).
Kohl, the Tour's best climber this year and third overall, is due to appear before the Austrian Anti-Doping Agency (NADA) on Monday.
He was supposed to join the Silence Lotto team from Gerolsteiner during the close season but the contract was declared void after it was revealed that retroactive tests showed traces of CERA (Continuous Erythropoiesis Receptor Activator) in his blood.
Kohl faces a two-year suspension from the sport, a sanction that could be cut if he cooperates with anti-doping authorities.
The length of the suspension is expected to be announced immediately after the NADA hearing.
Date created : 2008-11-23